Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-12
1997-05-27
Russel, Jeffrey E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435226, 530324, 930250, A61K 3857, C07K 1481, C12N 964
Patent
active
056332270
ABSTRACT:
This invention concerns methods of treating mast-cell mediated conditions in mammals, the methods comprising administering to the mammals pharmacologically active fragments or muteins of SLPI; methods of treating asthma or allergic rhinitis in mammals, the methods comprising administering to the mammals SLPI or pharmacologically active fragments or muteins thereof; methods for inhibiting tryptase; methods for identifying inhibitors of tryptase; and certain fragments and muteins of SLPI.
REFERENCES:
patent: 4356181 (1982-10-01), Payling et al.
patent: 4760130 (1988-07-01), Thompson et al.
patent: 4845076 (1989-07-01), Heinzel et al.
patent: 4845242 (1989-07-01), Powers et al.
patent: 4916117 (1990-04-01), Lezdey et al.
patent: 5089634 (1992-02-01), Powers et al.
patent: 5166134 (1992-11-01), Lezdey et al.
patent: 5190917 (1993-03-01), Lezdey et al.
patent: 5215965 (1993-06-01), Lezdey et al.
patent: 5217951 (1993-06-01), Lezdey et al.
patent: 5290762 (1994-03-01), Lezdey et al.
Agents and Actions, vol. 30, Nos. 1/2, issued 1990, Overveld, "Some aspects of mast cell subtypes from human lung tissue", pp. 24-29.
Biochemical Pharmacology, vol. 48, No. 4, issued 1994, Masuda et al, "Specific Cleavage of Secretory Leukoprotease Inhibitor . . . ", pp. 651-657.
Alter et al., "Interactions of Human Mast Cell Tryptase with Biological Protease Inhibitors", Arch. Biochem. Biophys. 276, 26-31 (1990).
Barnes, P. J., "Neuropeptides as Modulators of Airway Function", Mediators in Airway Hyperactivity, 175-196, (1990).
Caughey et al., "Substance P and Vasoactive Intestinal Peptide Degradation by Mast Cell Tryptase and Chymase", J. Pharmacol. Exp. Ther. 244, 133-137 (1988).
Crystal, R. G. and Roosdorp, N. J., "Aerosolization of Protein Therapeutic Agent", NTIS PAT-APPL-7 828 447 (1992).
Eisenberg et al., "Location of the Protease-inhibitory Region of Secretory Leukocyte Protease Inhibitor", J. Biol. Chem. 265, 7976-7981 (1990).
Grutter et al., "The 2.5 .ANG. X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine .alpha.-chymotrypsin", EMBO J. 7, 345-351 (1988).
Harvima et al., "Mast cell tryptase and chymase in developing and mature psoriatic lesions", Arch. Dermatol. Res. 285, 184-192 (1993).
Heinzel et al., "Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus", Eur. J. Biochem. 160, 61-67 (1986).
Hochstrasser et al., "Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respitory tract", Eur. Arch. Otorhinolaryngol. 249, 455-458 (1993).
Klasen, E. C. and Kramps, J. A. "The N-Terminal Sequence of Antileukoprotease Isolated from Bronchial Secretion", Biochem. Biophys. Res. Commun. 128, 285-289 (1985).
Kramps et al., "Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain", Biochim. Biophys. Acta. 1038, 178-185 (1990).
McElvaney et al., "Modulation of Airway Inflammation in Cystic Fibrosis", J. Clin. Invest. 90, 1296-1301 (1992).
Meckelein et al., "The location on inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yeilds an active inhibitor of three different proteinases", Protein Eng. 3, 215-220 (1990).
Ollerenshaw et al., "Absence of Immunoreactive Vasoactive Intestinal Polypeptide in Tissue from the Lungs of Patients with Asthma", N. Engl. J. Med. 320, 1244-1248 (1989).
Renesto et al., "Inhibition by recombinant SLPI and half-SLPI (Asn.sup.55 -Ala.sup.107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation", Br. J. Pharmacol. 108, 1100-1106 (1993).
Schwartz, L. B. and Bradford, T. R., "Regulation of Tryptase from Human Lung Mast Cells by Heparin", J. Biol. Chem. 261, 7372-7379 (1986).
Seemuller et al., "The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease)", FEBS Lett. 199, 43-48 (1986).
Smith et al., "Human Lung Tryptase", J. Biol. Chem. 259, 11046-11051 (1984).
Stolk et al., "Potency of an Oxidation-resistant Mutant of Secretory Leukocyte Proteinase Inhibitor in Lipopolysaccharide-induced Emphysema in Hamsters", Pul. Pharmacol. 6, 33-39 (1993).
Tam, E. K. and Caughey, G. H., "Degradation of Airway Neuropeptides by Human Lung Tryptase", Am. J. Respir. Cell. Mol. Biol. 3, 27-31 (1990).
Tanaka et al., "Mast Cell Tryptase, A New Target For Therapeutic Intervention In Asthma", Poster session handout for Symposium on Immunoregulation of Asthma II, Jun. 23, 1994, Quebec, Canada.
Thompson, R. C. and Ohlsson K., "Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase", Proc. Natl. Acad. Sci. USA 83, 6692-6696 (1986).
Van-Seuningen, I. and Davril, M., "Separation of the two domains of human mucus proteinase inhibitor : inhibitory activity is only located in the carboxy-terminal domain", Biochem. Biophys. Res. Commun. 179, 1587-1592 (1991).
Vogelmeier et al., "Aerolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium" 69, 1843-1848 (1990).
Wenzel et al., "Activation of Pulmonary Mast Cells by Bronchoalveolar Allergen Challenge", 137, 1002-1008 (1988).
Ying et al., "Functions of the N-Terminal Domain of Secretory Leukoprotease Inhibitor", Biochemistry 33, 5445-5450 (1994).
Brownell Elise
Delaria Katherine A.
Muller Daniel K.
Gray William F.
Miles Inc.
Russel Jeffrey E.
LandOfFree
Secretory leukocyte protease inhibitor as an inhibitor of trypta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Secretory leukocyte protease inhibitor as an inhibitor of trypta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Secretory leukocyte protease inhibitor as an inhibitor of trypta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329062